MHC molecules in health and disease: At the cusp of a paradigm shift

Self/Nonself - Immune Recognition and Signaling

Volumn 2, Issue 1, 2011, Pages 43-48

  de Almeida, Denise E ^a   Holoshitz, Joseph ^a  

^a UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

Author keywords

Autoimmunity; Disease; Evolution; Function; Hla; Structure

Indexed keywords

CALRETICULIN; CELL SURFACE RECEPTOR; EPITOPE; HLA DR ANTIGEN; HLA E ANTIGEN; INTERLEUKIN 17; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 1; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 2; NITRIC OXIDE; REACTIVE OXYGEN METABOLITE;

ADAPTIVE IMMUNITY; ALLELE; ALPHA HELIX; ANTIGEN PRESENTATION; ARTICLE; BINDING SITE; CELL DIFFERENTIATION; DISEASE PREDISPOSITION; DISEASE SEVERITY; HEALTH; HUMAN; INNATE IMMUNITY; IRON METABOLISM; MAJOR HISTOCOMPATIBILITY COMPLEX; MAJOR HISTOCOMPATIBILITY COMPLEX RESTRICTION; MHC CUSP THEORY; NONHUMAN; REGULATORY T LYMPHOCYTE; RHEUMATOID ARTHRITIS; SIGNAL TRANSDUCTION; SMELLING; TH17 CELL; THEORY;

EID: 79960356595     PISSN: 19382030     EISSN: 19382049     Source Type: Journal    
DOI: 10.4161/self.2.1.15757     Document Type: Article

References (45)

1. Marsh SG, Albert ED, Bodmer WF, Bontrop RE, Dupont B, Erlich HA, et al. Nomenclature for factors of the HLA system. Tissue Antigens 2010; 75:291-455 PMID: 20356336.
2. Zinkernagel RM, Doherty PC. The discovery of MHC restriction. Immunol Today 1997; 18:14-7 PMID: 9018968.
3. Rosloniec EF, Brand DD, Myers LK, Whittington KB, Gumanovskaya M, Zaller DM, et al. An HLADR1 transgene confers susceptibility to collageninduced arthritis elicited with human type II collagen. J Exp Med 1997; 185:1113-22 PMID: 9091584.
4. Ollier WE, Kennedy LJ, Thomson W, Barnes AN, Bell SC, Bennett D, et al. Dog MHC alleles containing the human RA shared epitope confer susceptibility to canine rheumatoid arthritis. Immunogenetics 2001; 53:669-73 PMID: 11797101.
5. Nishino S, Okuro M, Kotorii N, Anegawa E, Ishimaru Y, Matsumura M, et al. Hypocretin/orexin and narcolepsy: new basic and clinical insights. Acta Physiol 2010; 198:209-22 PMID: 19555382.
6. Shepherd CE, Piguet O, Broe GA, Creasey H, Waite LM, Brooks WS, et al. Histocompatibility antigens, aspirin use and cognitive performance in nondemented elderly subjects. J Neuroimmunol 2004; 148:178-82 PMID: 14975599.
7. Jawaheer D, Thomson W, MacGregor AJ, Carthy D, Davidson J, Dyer PA, et al. Homozygosity for the HLA-DR shared epitope contributes the highest risk for rheumatoid arthritis concordance in identical twins. Arthritis Rheum 1994; 37:681-6 PMID: 7514412.
8. Cardoso CS, de Sousa M. HFE, the MHC and hemochromatosis: Paradigm for an extended function for MHC class I. Tissue Antigens 2003; 61:263-75 PMID: 12753664.
9. Loconto J, Papes F, Chang E, Stowers L, Jones EP, Takada T, et al. Functional expression of murine V2R pheromone receptors involves selective association with the M10 and M1 families of MHC class Ib molecules. Cell 2003; 112:607-18 PMID: 12628182.
10. Simister NE, Jacobowitz Israel E, Ahouse JC, Story CM. New functions of the MHC class I-related Fc receptor, FcRn. Biochem Soc Trans 1997; 25:481-6 PMID: 9191140.
11. Jonsson AH, Yokoyama WM. Natural killer cell tolerance licensing and other mechanisms. Adv Immunol 2009; 101:27-79 PMID: 19231592.
12. Klein J. Origin of major histocompatibility complex polymorphism: The trans-species hypothesis. Hum Immunol 1987; 19:155-62 PMID: 3305436.
13. Brown JH, Jardetzky TS, Gorga JC, Stern LJ, Urban RG, Strominger JL, et al. Three-dimensional structure of the human class II histocompatibility antigen HLA-DR1. Nature 1993; 364:33-9 PMID: 8316295.
14. Rudolph MG, Stanfield RL, Wilson IA. How TCRs bind MHCs, peptides and coreceptors. Annu Rev Immunol 2006; 24:419-66 PMID: 16551255.
15. Boyington JC, Motyka SA, Schuck P, Brooks AG, Sun PD. Crystal structure of an NK cell immunoglobulin- like receptor in complex with its class I MHC ligand. Nature 2000; 405:537-43 PMID: 10850706.
16. Kaiser BK, Pizarro JC, Kerns J, Strong RK. Structural basis for NKG2A/CD94 recognition of HLA-E. Proc Natl Acad Sci USA 2008; 105:6696-701 PMID: 18448674.
17. Bennett MJ, Lebron JA, Bjorkman PJ. Crystal structure of the hereditary haemochromatosis protein HFE complexed with transferrin receptor. Nature 2000; 403:46-53 PMID: 10638746.
18. Olson R, Huey-Tubman KE, Dulac C, Bjorkman PJ. Structure of a pheromone receptor-associated MHC molecule with an open and empty groove. PLoS Biol 2005; 3:257 PMID: 16089503.
19. Ling S, Lai A, Borschukova O, Pumpens P, Holoshitz J. Activation of nitric oxide signaling by the rheumatoid arthritis shared epitope. Arthritis Rheum 2006; 54:3423-32 PMID: 17075829.
20. Ling S, Li Z, Borschukova O, Xiao L, Pumpens P, Holoshitz J. The rheumatoid arthritis shared epitope increases cellular susceptibility to oxidative stress by antagonizing an adenosine-mediated anti-oxidative pathway. Arthritis Res Ther 2007; 9:5 PMID: 17254342.
21. Holoshitz J, Ling S. Nitric oxide signaling triggered by the rheumatoid arthritis shared epitope: a new paradigm for MHC disease association? Ann NY Acad Sci 2007; 1110:73-83 PMID: 17911422.
22. Ling S, Pi X, Holoshitz J. The rheumatoid arthritis shared epitope triggers innate immune signaling via cell surface calreticulin. J Immunol 2007; 179:6359-67 PMID: 17947714.
23. De Almeida DE, Ling S, Pi X, Hartmann-Scruggs AM, Pumpens P, Holoshitz J. Immune dysregulation by the rheumatoid arthritis shared epitope. J Immunol 2010; 185:1927-34 PMID: 20592276.
24. Holoshitz J, De Almeida DE, Ling S. A role for calreticulin in the pathogenesis of rheumatoid arthritis. Ann NY Acad Sci 2010; 1209:91-8 PMID: 20958321.
25. Ling S, Cheng A, Pumpens P, Michalak M, Holoshitz J. Identification of the rheumatoid arthritis shared epitope binding site on calreticulin. PLoS One 2010; 5:11703 PMID: 20661469.
26. De Almeida DE, Ling S, Holoshitz J. New insights into the functional role of the rheumatoid arthritis shared epitope. FEBS Lett 2011; In Press PMID: 21420962.
27. Holoshitz J. The rheumatoid arthritis HLA-DRB1 shared epitope. Curr Opin Rheumatol 2010; 22:293-8 PMID: 20061955.
28. Mewar D, Marinou I, Coote AL, Moore DJ, Akil M, Smillie D, et al. Association between radiographic severity of rheumatoid arthritis and shared epitope alleles: differing mechanisms of susceptibility and protection. Ann Rheum Dis 2008; 67:980-3 PMID: 17901090.
29. Wucherpfennig KW, Strominger JL. Selective binding of self peptides to disease-associated major histocompatibility complex (MHC) molecules: a mechanism for MHC-linked susceptibility to human autoimmune diseases. J Exp Med 1995; 181:1597-601 PMID: 7722439.
30. La Cava A, Nelson JL, Ollier WE, MacGregor A, Keystone EC, Thorne JC, et al. Genetic bias in immune responses to a cassette shared by different microorganisms in patients with rheumatoid arthritis. J Clin Invest 1997; 100:658-63 PMID: 9239413.
31. Bhayani HR, Hedrick SM. The role of polymorphic amino acids of the MHC molecule in the selection of the T cell repertoire. J Immunol 1991; 146:1093-8 PMID: 1991960.
32. Tait BD, Drummond BP, Varney MD, Harrison LC. HLA-DRB1*0401 is associated with susceptibility to insulin-dependent diabetes mellitus independently of the DQB1 locus. Eur J Immunogenet 1995; 22:289-97 PMID: 7495781.
33. Korendowych E, Dixey J, Cox B, Jones S, McHugh N. The Influence of the HLA-DRB1 rheumatoid arthritis shared epitope on the clinical characteristics and radiological outcome of psoriatic arthritis. J Rheumatol 2003; 30:96-101 PMID: 12508396.
34. Chan MT, Owen P, Dunphy J, Cox B, Carmichael C, Korendowych E, et al. Associations of erosive arthritis with anti-cyclic citrullinated peptide antibodies and MHC Class II alleles in systemic lupus erythematosus. J Rheumatol 2008; 35:77-83 PMID: 18085741.
35. Doherty DG, Donaldson PT, Underhill JA, Farrant JM, Duthie A, Mieli-Vergani G, et al. Allelic sequence variation in the HLA class II genes and proteins in patients with autoimmune hepatitis. Hepatology 1994; 19:609-15 PMID: 8119685.
36. Dorak MT, Machulla HK, Hentschel M, Mills KI, Langner J, Burnett AK. Influence of the major histocompatibility complex on age at onset of chronic lymphoid leukaemia. Int J Cancer 1996; 65:134-9 PMID: 8567107.
37. Wen L, Chen NY, Tang J, Sherwin R, Wong FS. The regulatory role of DR4 in a spontaneous diabetes DQ8 transgenic model. J Clin Invest 2001; 107:871-80 PMID: 11285306.
38. Forsthuber TG, Shive CL, Wienhold W, de Graaf K, Spack EG, Sublett R, et al. T cell epitopes of human myelin oligodendrocyte glycoprotein identified in HLA-DR4 (DRB1*0401) transgenic mice are encephalitogenic and are presented by human B cells. J Immunol 2001; 167:7119-25 PMID: 11739534.
39. Lundberg AS, McDevitt HO. Evolution of major histocompatibility complex class II allelic diversity: direct descent in mice and humans. Proc Natl Acad Sci USA 1992; 89:6545-9 PMID: 1631156.
40. Gold LI, Eggleton P, Sweetwyne MT, Van Duyn LB, Greives MR, Naylor SM, et al. Calreticulin: non-endoplasmic reticulum functions in physiology and disease. FASEB J 2010; 24:665-83 PMID: 19940256.
41. Huang L, Baban B, Johnson BA, 3rd, Mellor AL. Dendritic cells, indoleamine 2,3 dioxygenase and acquired immune privilege. Int Rev Immunol 2010; 29:133-55 PMID: 20367139.
42. Thomas SR, Mohr D, Stocker R. Nitric oxide inhibits indoleamine 2,3-dioxygenase activity in interferongamma primed mononuclear phagocytes. J Biol Chem 1994; 269:14457-64 PMID: 7514170.
43. Chung DJ, Rossi M, Romano E, Ghith J, Yuan J, Munn DH, et al. Indoleamine 2,3-dioxygenaseexpressing mature human monocyte-derived dendritic cells expand potent autologous regulatory T cells. Blood 2009; 114:555-63 PMID: 19465693.
44. Kimura A, Kishimoto T. IL-6: regulator of Treg/ Th17 balance. Eur J Immunol 2010; 40:1830-5 PMID: 20583029.
45. Wucherpfennig KW, Call MJ, Deng L, Mariuzza R. Structural alterations in peptide-MHC recognition by self-reactive T cell receptors. Curr Opin Immunol 2009; 21:590-5 PMID: 19699075.